USPTO trademark

ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES

RegisteredUSPTOWord and designClass 35Class 36Class 44

"ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES" is a word and design mark owned by ImmunoGen, Inc., filed at the USPTO on November 28, 2022. It is registered and covers classes 35, 36 and 44.

View ImmunoGen, Inc. portfolioGet this data via the API
Official USPTO record
ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES trademark as filed
As filed with the USPTO
Status
Registered
Since June 18, 2024
Filed
November 28, 2022
Registered
June 18, 2024
Expires
Not recorded
Application no.
97693879
Registration no.
7423244
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
3 classes
Ownership

Who owns ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

ImmunoGen, Inc.

Waltham, United States

34 trademarks in the portfolioView company

Representative

Maryam S. Arastu

AbbVie Inc.

Goods and services

What the mark covers

The products and services ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES is filed for, grouped by Nice class.

  • Business administration of patient pharmaceutical reimbursement programs; business administration of a patient support program for facilitating access to, distribution of, and reimbursement for pharmaceutical products

  • Providing health insurance information about health insurance benefits, medication insurance coverage, insurance reimbursement, insurance payer policies and patient financial assistance to patients; financial consultation to medical patients in identification of health insurance alternatives; providing patient assistance programs, namely, providing financial assistance programs to provide access to pharmaceutical preparations at low or no cost to qualified uninsured and underinsured patients who have a demonstrated financial need

  • Informational counseling for patients, namely, providing information and assistance with respect to obtaining prescription medications for medical purposes

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Applicant/correspondence changes (non-responsive) entered
  5. Teas change of owner address received
  6. Notice of registration confirmation emailed
  7. Registered-principal register
  8. Notice of acceptance of statement of use e-mailed
  9. Allowed principal register - sou accepted
  10. Statement of use processing complete

10 earlier steps on the official record.

FAQ

About ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES

Who owns the trademark "ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES"?

The USPTO trademark "ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES" (application 97693879) is owned by ImmunoGen, Inc.

What is the status of "ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES"?

Its status at the USPTO is: registered.

When was "ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES" registered?

It was registered on June 18, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b25-d52a-7364-90bc-611ae96fc35f
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b25-d52a-7364-90bc-611ae96fc35f",
  "object": "trademark",
  "mark_text": "ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97693879",
  "filing_date": "2022-11-28",
  "nice_classes": [
    35,
    36,
    44
  ],
  "owners": [
    {
      "name": "ImmunoGen, Inc.",
      "entity_id": "ent_019f285f-45d5-72cf-a52d-252d88bfaab9"
    }
  ]
}